封面圖片

Renal Cell Carcinoma

Renal cancer is a health problem of major concern worldwide. Although tyrosine kinase inhibitors and immune check-point blockade treatments, alone or in combination, are giving promising results, failures are quite frequent due to intratumor heterogeneity and to the acquisition of drug resistance. T...

全面介紹

Saved in:
主要作者: López, José I.
格式: Online
語言:英语
出版: MDPI - Multidisciplinary Digital Publishing Institute 2021
主題:
QH301-705.5
Q1-390
N-glycomapping
n/a
SMAD proteins
patient survival
pro-IL-1?
survival prediction
inflammation markers
tumor migration
prognostic factors
practical approach
circular RNAs in a clinico-genomic predictive model
glycomarkers
review
nephrectomy
uric acid
VEGF inhibitors
metabolic reprogramming
collecting duct carcinoma
curcumin
metabolome profiling
identification of circular RNAs
IL-2
experimental validation of circular RNA
Raf/MEK/ERK
HOT
PI3K/Akt/mTOR
pentose phosphate pathway
kidney cancer
LOT
mutation
RCC
polybromo-1
pale cell
MMP-9
gene expression
recurrence free survival
chromosomal loss
IL-1?
chronic kidney disease
glutathione transferase omega 2
label-free
glutathione transferase omega 1
emerging entity
copy number alteration
FOXO3
predictive role
tumor slice culture
tyrosine kinase inhibitors
PPP
ESC
CDKN1A expression
metastasis
PD-L1
diagnostic and prognostic markers
EVI1
copy number loss
RNA sequencing
NK cells
glutathione metabolism
clear cell renal cell carcinoma
renal cell cancer
proliferation
eosinophilic variant
Xp11 translocation renal cell carcinoma
prognosis
invasion
immune infiltration
IL4R?
FISH
11) translocation renal cell carcinoma
tumor microenvironment
metabolome
hyperosmolality
toxicity
ALK
drug sensitivity
t(6
copy number analysis
urine
genetic association
polymorphism
solute carrier proteins
kidney
metastatic ccRCC
molecular genetic features
recurrence-free survival
chromophobe renal cell carcinoma
unclassified renal tumor
overall survival
mTOR inhibitors
mTOR
JAK2
von Hippel–Lindau
miR-155-5p
glycoproteomics
PBRM1
miR-133b
survival
TFE3
TFEB
oncocytic renal tumor
immune checkpoint inhibitors
biomarker
MMP10
TCGA
ghrelin
EMT like
checkpoint inhibitors
MiT family translocation renal cell carcinoma
gene signature
sarcomatoid
transforming growth factor beta
clear cell Renal Cell Carcinoma
tumor adhesion
renal cancer
unclassified renal cell carcinoma
Papillary renal cell carcinoma (pRCC)
miR-146a-5p
renal cell
everolimus
integrins
cytoreductive nephrectomy
immunotherapy
predictive factors
immunohistochemistry
MTA2
IL13R?1
targeted therapy
intratumour heterogeneity
aurora A
TCA cycle
AMP-activated protein kinases
cancer-specific survival
programmed death-ligand 1
efficacy
renal cell carcinoma
anaplastic lymphoma kinase rearrangement
TFEB-amplified renal cell carcinoma
statins
cancer immunotherapy
microRNA
new entity
proteome profiling
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
在線閱讀:46036
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

因特網

46036

相似書籍